Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Current Status and Prospects in the Treatment of Erectile Dysfunction by Adipose-Derived Stem Cells in the Diabetic Animal Model.

Yan H., Ding Y., Lu M.

Narrative Review on Systemic / IV, published in Sex Med Rev (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Sex Med Rev (2020)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
31980404
DOI
10.1016/j.sxmr.2019.09.006
Citations
13

Abstract (original English)

Introduction Erectile dysfunction (ED) is defined as the persistent inability to achieve and maintain an erection status sufficient to permit satisfactory sexual performance. Current evidence suggests that diabetes mellitus erectile dysfunction (DMED) is one of the leading causes of ED which remains a difficult condition to manage because of its complicated pathophysiological mechanisms. Recently, stem cell therapies have been added to the therapeutic treatment options for ED. Stem cells derived from adipose tissue are now considered an alternative approach to DMED with preliminary studies demonstrating their capability of promoting endothelial cell, smooth muscle cell, and cavernous nerve regeneration. Aim We will review the epidemiology and pathophysiology of ED, rat models, and adipose-derived stem cell (ASC) therapy and its effects. Methods The relevant literature and contemporary data, using keywords "adipose-derived stem cells and diabetes erectile dysfunction," were reviewed. Main outcome measure The main outcome measure was the evidence supporting the association between ASCs, diabetes ED, and rat model. Results ASCs can restore erectile function of DMED rats by promoting vascularization and neuralization of corpus cavernosum. They can also inhibit fibrosis and inflammation and protect smooth muscle cells. Conclusion ASCs have achieved satisfactory therapeutic effects i

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsDiabetes ComplicationsDiabetes Mellitus, ExperimentalDisease Models, AnimalErectile DysfunctionMalePluripotent Stem CellsRatsStem Cell Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research